What We Do

We partner with drug manufacturers to develop new drug launch strategies; forecast, maintain, or improve Medicaid access; design financial rebate models; resolve clinical or reimbursement challenges; and navigate complex and changing government regulations and policies.

No matter where a drug or product may fall in the pre- or post-launch pipeline, we develop and deliver the best possible strategy that allows favorable Medicaid access while protecting profitability.

 Medicaid Drug Launch Strategy

Medicaid Drug Launch Strategy

When developing a successful Medicaid access strategy, several things are necessary to understand: marketplace dynamics, competition and payer expectations, and the metrics used to make access decisions. Manufacturer miscalculations of these components are unfortunately common and can negatively impact Medicaid access. 

We understand the nuts and bolts of Medicaid, as our leadership team of former Medicaid officials created and continuously improved many of the metrics and policies that are still in use in the Medicaid arena. Since every U.S. state Medicaid program and pharmacy benefit managers have their own unique complexities, it's critical to rely on and trust in an expert, hands-on resource to guide you through an essential strategy for Medicaid success. That's Artia Solutions.

We streamline our Medicaid drug launch strategy for both pharmacy AND medical benefit products, as well as non-drug products such as medical supplies and digital therapeutics. We dive into our action plan by accurately predicting the level of access before launch, defining coverage requirements in a therapeutic class, identifying key barriers to access before launch, calculating the level of supplemental rebating required, developing clinical messaging through meetings and presentations with key decision-makers, and much more.

Supporting Artia Products

 Financial Modeling & Analysis

Financial Modeling & Analysis

As a crucial part of a Medicaid drug launch strategy, manufacturers must also understand where their product fits in the Medicaid financial landscape in order to maintain a competitive position. 

Our custom tools provide clients with an in-depth analytical view of their PDL category in order to decide whether or not to participate in a bid and what level of rebate is necessary to provide a competitive offer. Our analyses also assist our clients in developing competitive rebate structures in order to optimize Medicaid preferred drug list positioning. 

Additional analytical support includes bid submission, competitor net cost forecasting, Medicaid price increase and unit rebate impact forecasting, Medicaid gross-to-net ROI revenue modeling, and Medicaid utilization and cost data reporting.

Supporting Artia Products

 Product Monitoring & Market Access Support

Product Monitoring & Market Access Support

As a part of our post-launch strategy, our clinical team of PharmDs maintains custom-built technology that tracks the status of our clients' products. This includes updates on product and/or class status, new PDLs, new P&T/DUR meeting information, market share data, clinical and bid vendors, and much more.

We can also provide post-launch market access support through identifying engagement opportunities with Medicaid programs and prior authorization criteria support. It's critical for manufacturers to balance clinical market considerations with financial positioning in the Medicaid strategic planning process. We tailor our level of support depending on our clients' needs, whether that's working as an extension of their team or becoming our clients' market access team to cover all needs from beginning to end of the drug launch lifecycle.

Supporting Artia Products

 Legislation & Policy Research

Legislation & Policy Research

Stay one step ahead with Advantage+, our branch of services that specifically focuses on federal and state Medicaid legislation and policy. We study the latest policies in order to provide our clients with the most timely and relevant information related to their drugs in Medicaid. Advantage+ includes exclusive webinars, a monthly subscriber call, monthly newsletters, strategic one-on-one calls, and more.

We also partner with The Garner Group, a consulting and lobbying firm that uniquely specializes in direct advocacy on health policy issues in the political and regulatory environment. They assist clients in confidently navigating and influencing public and governmental healthcare policies and policymakers, while mitigating any risk of policy adoption delays.

Supporting Artia Products

 Crossroads Conference

Crossroads Conference

Crossroads: An Artia Solutions Conference is our biennial Medicaid conference in downtown Nashville. Our inaugural conference in 2018 was the first event of its kind for Medicaid stakeholders. In 2021, we brought together over 400 in-person and virtual attendees to explore issues impacting patient access to medications.

In 2023, we expect even more Medicaid pharmacy administrators, Medicaid Managed Care representatives, drug manufacturers, healthcare providers, pharmacists, advocacy groups, patients, public officials, and other Medicaid stakeholders to gather for impactful discussion.

The term Crossroads symbolizes our intent: to bring together separate sectors to find common ground and innovative solutions for issues related to Medicaid.

Our goal is to ignite bold conversations about pharmaceutical trends, healthcare reform, new regulations, state concerns, and more.

We hope you will join us on June 12-14, 2023, in Nashville at the downtown JW Marriott.